Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Chinese Research Group of Gallbladder Cancer (CRGGC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04140552
Recruitment Status : Recruiting
First Posted : October 28, 2019
Last Update Posted : October 28, 2019
Sponsor:
Collaborators:
The First Affiliated Hospital of Anhui Medical University
Anhui Provincial Hospital
First Affiliated Hospital Bengbu Medical College
LanZhou University
Henan Cancer Hospital
The First Affiliated Hospital of Zhengzhou University
The Second Affiliated Hospital of Harbin Medical University
First Affiliated Hospital of Harbin Medical University
Harbin Medical University
First Hospital of Jilin University
Second Hospital of Jilin University
China-Japan Union Hospital, Jilin University
Changshu NO.1 People's Hospital
Changzhou No.2 People's Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
The First People's Hospital of Taicang
Wuxi Second People's Hospital
Xuzhou Central Hospital
Second Affiliated Hospital of Suzhou University
Nantong University
The First People's Hospital of Nantong
The Affiliated Hospital of Xuzhou Medical University
Second Affiliated Hospital of Nanchang University
The First Affiliated Hospital of Nanchang University
Jiangxi Provincial People's Hopital
Shengjing Hospital
Baotou Central Hospital
Qinghai Provincial People's Hospital
Heping Hospital Affiliated to Changzhi Medical College
First Hospital of Shanxi Medical University
Shanxi Provincial Cancer Hospital
First Affiliated Hospital Xi'an Jiaotong University
Eastern Hepatobiliary Surgery Hospital
Shanghai Fengxian District Central Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Zhongshan Hospital
Shanghai Pudong Hospital
Central Hospital of Minhang District, Shanghai
Putuo District People's Hospital of Shanghai
Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Tianjin Medical University Cancer Hospital
First Affiliated Hospital of Xinjiang Medical University
The First Affiliated Hospital of Kunming Medical College
Yinzhou Hospital Affiliated to Medical School of Ningbo University
Shaoxing Second Hospital
Shaoxing People's Hospital
First Affiliated Hospital of Wenzhou Medical University
Sir Run Run Shaw Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Zhejiang Cancer Hospital
Huzhou Central Hospital
Ningbo No. 1 Hospital
People's Hospital of Hunan Province
Hainan People's Hospital
Taizhou Municipal Hospital
Xinghua City People's Hospital
Tongliao City Hospital
Jiangxi Provincial Cancer Hospital
Shandong Provincial Hospital
Qilu Hospital of Shandong University
The Affiliated Hospital of Qingdao University
Xijing Hospital
Information provided by (Responsible Party):
Yingbin Liu, MD, PhD, FACS, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Brief Summary:
The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.

Condition or disease
Gallbladder Neoplasms

Detailed Description:

The objectives of the CRGGC are as follows:

  1. To study the current diagnosis and treatment of gallbladder cancer in China.
  2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer.
  3. To improve the accurate staging of gallbladder cancer.
  4. To standardize the treatment with gallbladder cancer.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 10000 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 5 Years
Official Title: Chinese Research Group of Gallbladder Cancer
Actual Study Start Date : January 1, 2008
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2025

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Overall Survival [ Time Frame: 5 years ]
    The overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients from 2008 to 2020 diagnosed with gallbladder cancer in collaborated hospitals in China.
Criteria

Inclusion Criteria:

  • Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer).
  • Patients with accessible electronic medical record

Exclusion Criteria:

  • Patients with undetermined primary site of cancer.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04140552


Contacts
Layout table for location contacts
Contact: Yingbin Liu, MD, PhD +8613918803900 laoniulyb@163.com

Locations
Show Show 55 study locations
Sponsors and Collaborators
Shanghai Jiao Tong University School of Medicine
The First Affiliated Hospital of Anhui Medical University
Anhui Provincial Hospital
First Affiliated Hospital Bengbu Medical College
LanZhou University
Henan Cancer Hospital
The First Affiliated Hospital of Zhengzhou University
The Second Affiliated Hospital of Harbin Medical University
First Affiliated Hospital of Harbin Medical University
Harbin Medical University
First Hospital of Jilin University
Second Hospital of Jilin University
China-Japan Union Hospital, Jilin University
Changshu NO.1 People's Hospital
Changzhou No.2 People's Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
The First People's Hospital of Taicang
Wuxi Second People's Hospital
Xuzhou Central Hospital
Second Affiliated Hospital of Suzhou University
Nantong University
The First People's Hospital of Nantong
The Affiliated Hospital of Xuzhou Medical University
Second Affiliated Hospital of Nanchang University
The First Affiliated Hospital of Nanchang University
Jiangxi Provincial People's Hopital
Shengjing Hospital
Baotou Central Hospital
Qinghai Provincial People's Hospital
Heping Hospital Affiliated to Changzhi Medical College
First Hospital of Shanxi Medical University
Shanxi Provincial Cancer Hospital
First Affiliated Hospital Xi'an Jiaotong University
Eastern Hepatobiliary Surgery Hospital
Shanghai Fengxian District Central Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Zhongshan Hospital
Shanghai Pudong Hospital
Central Hospital of Minhang District, Shanghai
Putuo District People's Hospital of Shanghai
Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Tianjin Medical University Cancer Hospital
First Affiliated Hospital of Xinjiang Medical University
The First Affiliated Hospital of Kunming Medical College
Yinzhou Hospital Affiliated to Medical School of Ningbo University
Shaoxing Second Hospital
Shaoxing People's Hospital
First Affiliated Hospital of Wenzhou Medical University
Sir Run Run Shaw Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Zhejiang Cancer Hospital
Huzhou Central Hospital
Ningbo No. 1 Hospital
People's Hospital of Hunan Province
Hainan People's Hospital
Taizhou Municipal Hospital
Xinghua City People's Hospital
Tongliao City Hospital
Jiangxi Provincial Cancer Hospital
Shandong Provincial Hospital
Qilu Hospital of Shandong University
The Affiliated Hospital of Qingdao University
Xijing Hospital
Investigators
Layout table for investigator information
Principal Investigator: Yingbin Liu, MD, PhD Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Layout table for additonal information
Responsible Party: Yingbin Liu, MD, PhD, FACS, Prof., Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
ClinicalTrials.gov Identifier: NCT04140552    
Other Study ID Numbers: CRGGC_LYB_2019
First Posted: October 28, 2019    Key Record Dates
Last Update Posted: October 28, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No plan for IPD access is scheduled.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Yingbin Liu, MD, PhD, FACS, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine:
gallbladder neoplasms
gallbladder cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Gallbladder Neoplasms
Neoplasms
Biliary Tract Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Biliary Tract Diseases
Digestive System Diseases
Gallbladder Diseases